Company Analysis

Faeth Therapeutics, Inc. (FTH)

Nasdaq: FTH · Pharmaceutical Preparations · Rockville, MD · filing with the SEC since 2020
Grade5.2
◀ Past 6.3● Present 4.1▶ Future 5.4
6 est.

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Report filedMar 30, 2026Mar 28, 2025Feb 29, 2024Mar 29, 2023Mar 15, 2022Mar 30, 2021
General and administrative11,32813,03618,76519,80515,8207,528
Total operating expenses22,28832,61437,06450,18837,48219,451
Operating income-22,288-32,614-37,064-50,188-37,482-19,451
Interest expense32901442196701,689
Interest and investment income1,2392,5503,6241,783800·
Other income (expense), net-4-3-21536-9·
Income before income taxes-21,085-30,157····
Income tax expense00····
Net income including non-controlling interests-21,085-30,157-34,101-48,588-36,794-20,100
Net income-21,085-30,157-34,101-48,588-36,794-20,100
Net income to common shareholders-21,085-30,157-34,101-48,588-36,794-20,204
Earnings per share, basic-16.72-24.01r-24.40b-31.60b-26.60b·
Earnings per share, diluted-16.72-24.01r-24.40b-31.60b-26.60b·
Earnings per share, basic and diluted····-26.60b-250.60b
Weighted average shares, basic1,260,7721,255,776r1,397,643b1,535,165b1,385,534b·
Weighted average shares, diluted1,260,7721,255,776r1,397,643b1,535,165b1,385,534b·
Weighted average shares, basic and diluted····1,385,534b80,607b
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-20 reverse split of Jun 2025.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeNet
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton FTH · research, not advice